ACE2 and Hyperglycemia: Among diabetes patients, the ACE2 expression is also increased, and hyperglycemia can induce the glycation of ACE2, which may also increase the entry of SARS-CoV-2 into the cells, leading to increased inflammation and hyper-immune responses [26,27].